According to Ruchi Mallya, the author of the report, it has become imperative for the pharma companies to utilize advanced computerized systems and IT solutions in drug safety monitoring in order to survive in the proactive pharmacovigilance environment. Ms Mallya also said that data mining and signal detection technologies can be effectively used in bringing down the soaring R&D costs.
The report claims that the use of sophisticated pharmacovigilance solutions will greatly help the pharmaceutical manufacturers in cutting down costs and time involved in drug development process.
The report also predicts that as the advantages of the new pharmacovigilance solutions become visible, the drug makers will increasingly adopt the IT solutions to achieve better results in drug safety monitoring.